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ABSTRACT  Sensitivity to penicillin G of 190 Streptococcus pneumoniae strains detected by 
sputum culture from January 2006 to December 2011 was investigated using old criteria (PSSP: 
0.06 μ g/ml or less, PISP: 0.12～1μg/ml, PRSP: 2μg/ml or greater) and new criteria (without 
meningitis) (PSSP: 2 μ g/ml or less, PISP: 4μg/ml, PRSP: 8μg/ml or greater). The results by 
the old criteria were PSSP: 43.2%, PISP: 44.7%, and PRSP: 12.1%, whereas the results by the 
new criteria were PSSP: 97.4%, PISP: 2.1 %, and PRSP: 0.5%. Based on the above, it was 
concluded that the majority of S. pneumoniae from sputum were penicillin-sensitive strains.
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INTRODUCTION
   With regard to Streptococcus pneumoniae, 
the National Committee for Clinical Laboratory 
Standards (NCCLS)１） in the USA has, until 
recently, defined Penicillin-Sensitive S. pneumoniae 
(PSSP) as a penicil l in G (PCG)  minimum 
inhibitory concentration (MIC) of 0.06 μg/m1 
or less, Penicillin-Intermediate S. pneumoniae 
(PISP) as 0.12~1μg/m1, and Penicillin-Resistant 
S. pneumoniae (PRSP) as 2 μg/ml or greater. 
However,  new NCCLS cr i te r ia２） (wi thout 
meningitis) define PSSP as 2 μg/ml or less, PISP 
as 4μg/ml and PRSP as 8 μg/ml or greater. To 
evaluate whether a change in frequency of PRSP 
obtained from the sputum would occur as a result of 
this criteria change, we investigated the difference 
in incidence of PRSP by both the old criteria and the 
new criteria.   
MARERIALS AND METHODS
Materials
   The materials were 190 S. pneumoniae strains 
detected by sputum culture at Kawasaki Hospital, 
Kawasaki Medical School from January 2006 to 
December 2011.
   S. pneumoniae strains were obtained from 190 
patients (118 males and 72 females aged 27 to 91 
years,187 outpatients and 3 inpatients).
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Methods
   We measured MIC of PCG for these strains and 
compared their sensitivities using the old and new 
criteria. 
   The MIC was measured by microbroth dilution 
method.
RESULT (Fig.1)
   According to the old criteria, of the 190 strains, 
82 strains (43.2%) were PSSP, 85 strains (44.7%) 
were PISP, and 3 strains (12.1%) were PRSP. On the 
other hand, according to the new criteria, of the 190 
strains, 185 strains (97.4%) were PSSP, 4 strains 
(2.1%) were PISP, and 1 strain (0.5%) was PRSP. 
DISCUSSION
   The world’s first PRSP was reported in 1965３）. 
The first case in Japan was reported４） in 1977. 
Thereafter, PRSP have spread. A nationwide 
surveillance in 2008５） revealed that 52.6% were 
PSSP, 35.5% were PISP, and 11.8% were PRSP, 
showing that nearly half of S. pneumoniae are 
penicillin-resistant. This rapid increase has become 
a major concern.
   However, in the clinical setting, the strategy of 
treating even pneumonia caused by PRSP was 
recommended penicillin, because pneumonia caused 
by PRSP has been cured when a sufficient amount of 
penicillin is administered. The new criteria (without 
meningitis) stipulate PSSP as 2μg/ml or less, 
thus many strains which had been conventionally 
judged to be PRSP are now judged to be PSSP. The 
present study showed that results of PSSP: 43.2%, 
PISP: 44.7%, and PRSP: 12.1% by the old criteria 
changed to PSSP: 97.44%, PISP: 2.1 %, and PRSP 
0.5% by the new criteria, showing that the majority 
of strains are penicillin-sensitive strains. Another 
Japanese study on 211 stains performed in 2008５） 
showed that results of PSSP: 52.6%, PISP: 35.5%, 
and PRSP: 99.5% by the old criteria changed to 
PSSP: 99.5%, PISP: 0.5%, and PRSP: 0% by the 
new criteria, showing that nearly all the strains were 
penicillin-sensitive. A study performed６） in the USA 
in 2006 on 2897 strains revealed PSSP: 93.0%, PISP 
6.3%, and PRSP 0.7% by the new criteria, showing 
that nearly all the strains were penicillin-sensitive. 
Fig. 1.　Incidence of Penicillin-Resistant Streptococcus pneumoniae
（190 strains by sputum culture, 2006～2011）
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These results clarified the reason that administration 
of penicillin cured even pneumonia caused by S. 
pneumoniae which have been conventionally judged 
to be penicillin-resistant. 
   Based on the above, it was concluded that the 
majority of S. pneumoniae detected from sputum is 
penicillin-sensitive and the drug of first choice for S. 
pneumoniae pneumonia should be penicillin.   
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